Injection Pen Market

Injection Pen Market Outlook (2024 to 2034)

Rising acceptance of injection pens for addressing a wide spectrum of medical issues is set to drive their demand across regions. The global injection pen market growth has been forecasted to increase at 7.2% CAGR and reach US$ 93.4 billion by the end of 2034, up from US$ 46.72 billion in 2024.

An increasing number of chronic diseases, increasing incidences of regulatory approvals, and favorable reimbursement policies and government support are resulting in the rising sales of injection pens. Moreover, constant efforts put forward by manufacturers of injection pens for the development of more effective products are set to increase their demand in the coming 10 years.

Injection pens are used as one of the vital medical devices as numerous chronic conditions need frequent administration of medications. Injection pens are used as one of the standard replacements for delivery methodologies for injectable medication. Their growing popularity is attributed to convenience and the ability to be administrated directly by the majority of patients that too without any assistance of a medical professional.

• South Asia & Pacific is calculated to account for 22.7% of the injection pen market share by the end of 2034.
• Sales of injection pens in Canada are projected to rise at 11.2% CAGR from 2024 to 2034.
• Hospitals are estimated to hold 32% share of the global market by 2034-end.

Comparatively pocket-friendly cost of injection pens is estimated to make them easily accessible to patients of different age groups and geographies. The increasing population of geriatric people is set to contribute to the rising demand for injection pens due to immunity deterioration, which results in a growing count of health issues, such as diabetes and cardiovascular diseases. According to the research report published by the International Agency for Research on Cancer, the count of cancer cases and related deaths is increasing around the world, which is generating demand for injection pens.

Adoption of technologically advanced reusable pens is projected to generate lucrative opportunities for suppliers. These newly developed pens are equipped with Bluetooth technology for the calculation of insulin doses, therefore ensuring convenience to respective patients.

Report Attributes	Details
Injection Pen Market Size (2024E)	US$ 46.72 Billion
Forecasted Market Value (2034F)	US$ 93.4 Billion
Global Market Growth Rate (2024 to 2034)	7.2% CAGR
Market Share of Reusable Injections (2034F)	62%
Japan Market Growth Rate (2024 to 2034)	2.8% CAGR
Western Europe Market Share (2034F)	16.8%
Key Companies Profiled	Novo Nordisk A/S; Sun Pharmaceutical Industries Ltd.; Medtronic plc; Braun Medical; Becton,; Terumo Medical Corporation; Ypsomed AG; Dickinson and Company; Owen Mumford Ltd.; Hoffmann-La Roche Ltd.; Sanofi; AstraZeneca; Merck; Eli Lilly and Company

What is Set to Positively Drive Global Sales of Injection Pens?

“Increasing Number of Health Issues Resulting in High Need for Injection Pens for Medication Authentication”

Increasing population of geriatric people is leading to rising incidences of health issues, due to weaker immune systems. The chances of getting several health disorders, such as diabetes, cardiovascular diseases, etc., increase, which leads to the demand for injection pens to authenticate the dosage used. Further, certain downsides associated with conventional syringes are stimulating more patients to adopt advanced injection pens.

Growing investments in the development of novel medications are increasing the demand for injection pens for the effective administration of medications. In addition, awareness among more patients related to the availability of convenient and novel infection pens is also contributing to their sales.

What’s Restricting the Injection Pen Market Size from Reaching its Full Potential?

“Lack of Sufficient Knowledge about Using Injection Pens”

Inadequate guidance and training for the utilization of advanced delivery devices, such as injectable pens, etc., are projected to lead to their inappropriate use, therefore, exposing healthcare personnel and patients to danger. This is adversely impacting demand for injection pens across hospital settings. In addition, injection pens generally carry insulin of different strengths. This is anticipated to increase the risks associated with overdose if the dose is not measured. Growing concerns related to injuries caused due to needles are also hampering the demand for injection pens.

What is the Contribution of Startups in Shaping This Business?

“Development of Injection Pens with Features to Administer Exact Dosage and Improved Memory”

Technological advancements in injection pens are projected to contribute to market growth. New players are expected to invest in technological developments, including offering precise dosage administration and improved memory, which is anticipated to help them secure a position for themselves.

Country-wise Insights

North America is expected to hold 36.7% share of global market revenue by 2034 owing to the rising number of diabetic patients, which are the prominent contributors to market revenue. Further, the regional presence of some key players is also contributing to the injection pen market growth there.

Which Injection Pen Market Trends are Benefiting the United States Market?

“Popularity of Injection Pens for Medicine Administration”

Attribute	United States
Market Value (2024E)	US$ 14.3 Billion
Growth Rate (2024 to 2034)	8.6% CAGR
Projected Value (2034F)	US$ 32.74 Billion

The United States is approximated to account for 83.3% of the North American market revenue share by the end of 2034. The growing pool of diabetic patients along with the increasing prevalence of chronic ailments are contributing to the popularity of injection pens in homecare settings. In addition, the presence of some of the prominent suppliers of injection pens in the country is also helping the market expand. They are also used for the administration of medicines in prescribed doses of pediatric patients and infants.

What are the Growth Prospects for Injection Pen Suppliers in China?

“Increasing Burden of Diabetes and Expanding Healthcare Infrastructure”

Attribute	China
Market Value (2024E)	US$ 3.51 Billion
Growth Rate (2024 to 2034)	9.4% CAGR
Projected Value (2034F)	US$ 8.62 Billion

China is projected to hold 54.5% share of the East Asian market share by 2034-end. Growing cases of diabetes in the country along with an expansion of the healthcare infrastructure is projected to create lucrative opportunities for market players. Moreover, the willingness of more individuals to spend more on advanced therapeutics and healthcare facilities is driving demand for injection pens in China.

Category-wise Insights

As mentioned in a study published by Fact.MR, a market research and competitive intelligence provider, hospitals are expected to hold 32% share of global market revenue by 2034-end. The growing inclination to hospitals for getting injection pens is attributed to the reliability of the products received.

Why is Demand for Reusable Injection Pens Increasing Faster?

“Pocket-friendly Prices of Reusable Pens”

Attribute	Reusable Pens
Segment Value (2024E)	US$ 28.66 Billion
Growth Rate (2024 to 2034)	7.3% CAGR
Projected Value (2034F)	US$ 57.87 Billion

Reusable pens are forecasted to account for 62% share of the global market by the end of 2034. Conventional injection methods have been replaced with some more convenient and advanced options. The development of reusable injection pens is one of such improvements, which ensure accuracy in the drug delivery process. Furthermore, no cartridges are required for these injections. Users only need to replace needles therefore are considered cost-effective for medication delivery to the human body.

Which Indication Accounts for Higher Usage of Injection Pens?

“Diabetic Patients Account for Leading Share of Global Market Revenue”

Attribute	Diabetes
Segment Value (2024E)	US$ 25.99 Billion
Growth Rate (2024 to 2034)	6.8% CAGR
Projected Value (2034F)	US$ 50.33 Billion

Injection pens are generally used against the management and treatment of multiple diseases, including autoimmune diseases, growth hormone therapy, diabetes, and others. Among these, diabetic patients are projected to account 53.9% of global market revenue share by 2034-end. Increasing demand from the majority of diabetic patients for convenient and safer insulin delivery methods is contributing to the adoption of injection pens. Recent technological advancements in injection pens along with approvals from numerous international organizations are supporting their increased sales.

Competitive Landscape

Companies operating in the global market are concentrating on expanding their footprints across regions through collaborations around the world. Multiple companies are incorporating acquisitions, mergers, and partnerships to strengthen their presence across regions. In addition, new product developments, maintaining product quality, and strengthening systems used for product supply are helping them secure a position for themselves.

Key players in the injection pen market are Novo Nordisk A/S, Sun Pharmaceutical Industries Ltd., Medtronic plc, Braun Medical, Becton, Terumo Medical Corporation, Ypsomed AG, Dickinson and Company, Owen Mumford Ltd., Hoffmann-La Roche Ltd., Sanofi, AstraZeneca, Merck, and Eli Lilly and Company.

Segmentation of Injection Pen Market Research

• By Type :

  • Reusable
  • Disposable

• By Indication :

  • Anaphylaxis
  • Diabetes
  • Cardiovascular Diseases
  • Multiple Sclerosis
  • Rheumatoid Arthritis
  • Cancer

• By Distribution Channel :

  • Online Pharmacies
  • Drug Stores
  • Retail Pharmacies
  • Hospitals

• By Region :

  • North America
  • Europe
  • East Asia
  • Latin America
  • Middle East & Africa
  • South Asia & Oceania